1. Home
  2. HUCK vs HUMA Comparison

HUCK vs HUMA Comparison

Compare HUCK & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HUCK

Huckleberry.ai Inc. Class B Common Stock

N/A

Current Price

$3.11

Market Cap

159.5M

Sector

Technology

ML Signal

N/A

Logo Humacyte Inc.

HUMA

Humacyte Inc.

BUY

Current Price

$0.43

Market Cap

165.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
HUCK
HUMA
Founded
2010
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
159.5M
165.7M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
HUCK
HUMA
Price
$3.11
$0.43
Analyst Decision
Hold
Buy
Analyst Count
2
5
Target Price
★ $4.17
$1.63
AVG Volume (30 Days)
759.0K
★ 5.7M
Earning Date
12-03-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
31.92
★ 79.37
EPS
N/A
★ N/A
Revenue
★ $318,857,000.00
$2,038,000.00
Revenue This Year
N/A
$72.32
Revenue Next Year
$1.33
$518.79
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 0.57
N/A
52 Week Low
$2.96
$0.34
52 Week High
$3.55
$1.78

Technical Indicators

Market Signals
Indicator
HUCK
HUMA
Relative Strength Index (RSI) 39.30 41.96
Support Level $2.99 $0.34
Resistance Level $3.24 $0.46
Average True Range (ATR) 0.13 0.04
MACD -0.00 0.01
Stochastic Oscillator 50.85 55.07

Price Performance

Historical Comparison
HUCK
HUMA

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: